Ryan Specialty Holdings（RYAN）株式概要ライアン・スペシャルティ・ホールディングスは、米国、カナダ、英国、その他の欧州諸国、インド、シンガポール、および世界各国において、保険ブローカー、代理店、保険会社向けに特殊商品やソリューションを提供するサービス・プロバイダーとして事業を展開している。 詳細RYAN ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長4/6過去の実績4/6財務の健全性3/6配当金2/6報酬収益は年間44.8%増加すると予測されています 過去1年間で収益は71.3%増加しました リスク分析負債は営業キャッシュフローで十分にカバーされていない 財務結果に影響を与える大きな一時的項目 すべてのリスクチェックを見るRYAN Community Fair Values Create NarrativeSee what 11 others think this stock is worth. Follow their fair value or set your own to get alerts.Analyst Price TargetsAN15.1% undervaluedAnalystConsensusTarget•8d agoAnalysts Weigh Resilient Margins and Growth Outlook for Ryan Specialty Holdings Amid Valuation Shifts33005AN26.6% overvaluedAnalystLowTarget•1mo agoAI Automation And Compliance Costs Will Depress Broker Margins3901AN36.0% undervaluedAnalystHighTarget•2mo agoRising Climate And Cyber Risks Will Boost Insurance Demand3900Top Analyst NarrativesAN15.1% undervaluedAnalystConsensusTarget•8d agoAnalysts Weigh Resilient Margins and Growth Outlook for Ryan Specialty Holdings Amid Valuation Shifts33005AN26.6% overvaluedAnalystLowTarget•1mo agoAI Automation And Compliance Costs Will Depress Broker Margins3901AN36.0% undervaluedAnalystHighTarget•2mo agoRising Climate And Cyber Risks Will Boost Insurance Demand3900View all narrativesRyan Specialty Holdings, Inc. 競合他社Brown & BrownSymbol: NYSE:BROMarket cap: US$23.9bHagertySymbol: NYSE:HGTYMarket cap: US$4.4bNeptune Insurance HoldingsSymbol: NYSE:NPMarket cap: US$4.4bWillis Towers WatsonSymbol: NasdaqGS:WTWMarket cap: US$31.2b価格と性能株価の高値、安値、推移の概要Ryan Specialty Holdings過去の株価現在の株価US$43.0452週高値US$60.3452週安値US$29.28ベータ0.571ヶ月の変化5.26%3ヶ月変化31.70%1年変化-28.06%3年間の変化-6.35%5年間の変化35.13%IPOからの変化56.51%最新ニュースナラティブ更新 • Aug 13RYAN: Share Repurchases Will Support Q2 Momentum Through Softer Pricing CycleAnalysts recently lifted the fair value estimate for Ryan Specialty Holdings from $45.88 to $50.72, reflecting higher Street price targets in the $39 to $69 range and updated assumptions for slightly stronger revenue growth, wider profit margins and a lower future P/E multiple. Analyst Commentary Recent research on Ryan Specialty Holdings shows a mix of optimism and caution, with many firms adjusting price targets higher while still debating the durability of growth and the right valuation level for the stock.Reported Earnings • Jul 31Second quarter 2026 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2026 results: EPS: US$0.34 (down from US$0.41 in 2Q 2025). Revenue: US$916.6m (up 9.0% from 2Q 2025). Net income: US$42.3m (down 19% from 2Q 2025). Profit margin: 4.6% (down from 6.2% in 2Q 2025). Revenue exceeded analyst estimates by 5.4%. Earnings per share (EPS) also surpassed analyst estimates by 3.9%. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year.お知らせ • Jul 31Ryan Specialty Holdings, Inc. Declares Quarterly Dividend on the Outstanding Class A Common Stock, Payable on August 25, 2026On July 30, 2026, Ryan Specialty Holdings, Inc.'s board of directors declared a quarterly dividend of $0.13 per share on the outstanding Class A common stock. The quarterly dividend will be payable on August 25, 2026, to stockholders of record as of the close of business on August 11, 2026.ナラティブ更新 • Jul 30RYAN: Softer Pricing And Buybacks Will Offset Catastrophe And Cycle RisksRyan Specialty Holdings' analyst fair value estimate has been revised higher to $45.88 from $43.29 as analysts factor in updated price targets across the Street, along with a mix of views on how soft commercial pricing, catastrophe exposure and recent buyback activity could influence growth, profitability and future P/E assumptions. Analyst Commentary Recent Street research on Ryan Specialty Holdings shows a mix of optimism and caution around growth, execution and valuation as commercial pricing softens and catastrophe trends remain a focus.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to US$46.48, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 12x in the Insurance industry in the US. Total returns to shareholders of 8.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$22.72 per share.ナラティブ更新 • Jul 16RYAN: Prolonged P&C Price Softening Will Challenge Execution Against Growth ExpectationsAnalysts trimmed the Ryan Specialty fair value estimate to $34 from $36, reflecting slightly higher discount rate assumptions and more cautious views on revenue growth, profit margins, and future P/E in light of recent mixed shifts in Street price targets across the insurance broker group. Analyst Commentary Street research on Ryan Specialty Holdings shows a mixed backdrop, with several price target raises alongside more cautious views on growth, valuation, and the commercial property and casualty cycle.最新情報をもっと見るRecent updatesナラティブ更新 • Aug 13RYAN: Share Repurchases Will Support Q2 Momentum Through Softer Pricing CycleAnalysts recently lifted the fair value estimate for Ryan Specialty Holdings from $45.88 to $50.72, reflecting higher Street price targets in the $39 to $69 range and updated assumptions for slightly stronger revenue growth, wider profit margins and a lower future P/E multiple. Analyst Commentary Recent research on Ryan Specialty Holdings shows a mix of optimism and caution, with many firms adjusting price targets higher while still debating the durability of growth and the right valuation level for the stock.Reported Earnings • Jul 31Second quarter 2026 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2026 results: EPS: US$0.34 (down from US$0.41 in 2Q 2025). Revenue: US$916.6m (up 9.0% from 2Q 2025). Net income: US$42.3m (down 19% from 2Q 2025). Profit margin: 4.6% (down from 6.2% in 2Q 2025). Revenue exceeded analyst estimates by 5.4%. Earnings per share (EPS) also surpassed analyst estimates by 3.9%. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year.お知らせ • Jul 31Ryan Specialty Holdings, Inc. Declares Quarterly Dividend on the Outstanding Class A Common Stock, Payable on August 25, 2026On July 30, 2026, Ryan Specialty Holdings, Inc.'s board of directors declared a quarterly dividend of $0.13 per share on the outstanding Class A common stock. The quarterly dividend will be payable on August 25, 2026, to stockholders of record as of the close of business on August 11, 2026.ナラティブ更新 • Jul 30RYAN: Softer Pricing And Buybacks Will Offset Catastrophe And Cycle RisksRyan Specialty Holdings' analyst fair value estimate has been revised higher to $45.88 from $43.29 as analysts factor in updated price targets across the Street, along with a mix of views on how soft commercial pricing, catastrophe exposure and recent buyback activity could influence growth, profitability and future P/E assumptions. Analyst Commentary Recent Street research on Ryan Specialty Holdings shows a mix of optimism and caution around growth, execution and valuation as commercial pricing softens and catastrophe trends remain a focus.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to US$46.48, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 12x in the Insurance industry in the US. Total returns to shareholders of 8.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$22.72 per share.ナラティブ更新 • Jul 16RYAN: Prolonged P&C Price Softening Will Challenge Execution Against Growth ExpectationsAnalysts trimmed the Ryan Specialty fair value estimate to $34 from $36, reflecting slightly higher discount rate assumptions and more cautious views on revenue growth, profit margins, and future P/E in light of recent mixed shifts in Street price targets across the insurance broker group. Analyst Commentary Street research on Ryan Specialty Holdings shows a mixed backdrop, with several price target raises alongside more cautious views on growth, valuation, and the commercial property and casualty cycle.ライブニュース • Jul 15Ryan Specialty Launches Renewables Unit and Names Jeff Smith as CEORyan Specialty Holdings has created Ryan Specialty Renewables as a unified managing general underwriting platform for renewable and energy transition solutions and appointed Jeff Smith as CEO. The rebranding of PERse North America, PERse International and Albus is expected to be completed in Q3 2026. The consolidation brings the company’s existing renewable-focused MGUs under one global platform aimed at offering a broad set of insurance products and services to middle-market and large renewable energy clients. Ryan Specialty’s stock trades at US$40.66, with the share price down 19.7% year to date, while this renewables build-out is being put in place. The new Ryan Specialty Renewables unit concentrates the group’s expertise in one area, which could sharpen its offering to large renewable energy projects but also increases the company’s exposure to a specialized segment that can be competitive and reliant on project volumes.ライブニュース • Jul 06Ryan Specialty Secures Lloyd’s Consortium Support for Global Underwriting PortfolioRyan Specialty Underwriting Managers has completed a series of Lloyd’s of London consortium stamps backed by six leading syndicates, which will take a combined 15% share of its global syndicated property and casualty delegated underwriting portfolio across all classes and geographies, excluding Velocity Risk Underwriters, starting at natural renewals from 1 August 2026. These consortium stamps expand access to Lloyd’s capital for Ryan Specialty’s delegated underwriting platform, directly affecting how risk is syndicated and potentially supporting the scale and breadth of its global property and casualty facilities. Ryan Specialty Holdings’ stock trades at $42.03, with the share price up 29.1% over the past 30 days. This Lloyd’s-backed capacity arrangement gives Ryan Specialty clearer visibility on future underwriting support for its delegated portfolio, but investors will still need to watch how the 15% allocation is utilized across classes and geographies, and how it affects underwriting results once the facilities renew from 2026 onward.お知らせ • Jul 04Ryan Specialty Holdings, Inc. to Report Q2, 2026 Results on Jul 30, 2026Ryan Specialty Holdings, Inc. announced that they will report Q2, 2026 results After-Market on Jul 30, 2026ナラティブ更新 • Jul 01RYAN: Softer Pricing And Buybacks Will Shape Earnings Resilience OutlookAnalysts have reset the fair value estimate for Ryan Specialty Holdings to $43.29 from $55.25. This reflects a series of revised price targets around $39 to $44 as they factor in softer commercial property and casualty pricing alongside resilient earnings and margins.Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$38.88, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 10% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$25.51 per share.ライブニュース • Jun 25RT Specialty Sets CEO Succession as Mulshine to Succeed McCormack in 2026Ryan Specialty’s wholesale arm RT Specialty announced a leadership succession plan effective August 1, 2026, with current CEO Ed McCormack moving to Vice Chairman through 2027 and Co-President of Ryan Specialty Brendan Mulshine set to become CEO of RT Specialty. The planned transition involves a core business within Ryan Specialty and places Mulshine in charge of leading growth initiatives and deepening client and carrier relationships, while keeping McCormack involved at the board level. Ryan Specialty shares trade at US$35.28, with the stock down 30.3% year to date, putting extra focus on how leadership changes at RT Specialty align with execution across the broader group. A clearly flagged succession timeline gives you more visibility on leadership continuity at Ryan Specialty, but it also concentrates attention on execution risk around 2026 and 2027 as Mulshine steps into a key operating role.ナラティブ更新 • Jun 17RYAN: Expanded Buyback And Insider Buying Will Support Future Share PriceThe analyst price target for Ryan Specialty Holdings has narrowed slightly to align with a mix of recent cuts and one increase across the Street, reflecting concerns about softer commercial property and casualty pricing, alongside support from the expanded $300M share buyback program. Analyst Commentary Recent research on Ryan Specialty Holdings shows a split view, with some firms trimming expectations around commercial property and casualty trends while others point to shareholder returns and execution as support for the stock.ライブニュース • Jun 17Ryan Specialty Stock Gains Insider Support With $300M Buyback After 50% DeclineRyan Specialty insiders, including the CFO and two directors, recently bought shares in open-market transactions totaling more than US$560,000, increasing their personal stakes in the company. The company expanded its stock repurchase program by US$300m after using up its previous authorization. Ryan Specialty reported first-quarter revenue growth of 15.2% year over year and guided to mid-single-digit revenue growth. Insider purchases combined with a larger buyback program indicate that company leadership is willing to commit capital to Ryan Specialty stock, even after a share price decline of more than 50% over the past year. At the same time, investors may want to weigh this indication of confidence against concerns raised around operating margins and cash burn, as well as the mixed analyst views noted in recent research.ライブニュース • Jun 09Ryan Specialty Holdings Faces Legal Scrutiny as Executives Increase Share Purchases and Buyback ProgramThe Schall Law Firm has opened an investigation into Ryan Specialty Holdings over potential securities law violations tied to alleged false or misleading disclosures and material omissions. The investigation follows the company’s Q4 and full-year 2025 results, after which the stock fell sharply as investors reacted to weaker organic revenue growth, margin pressure and challenging property pricing trends. Around the same time, CFO Janice M Hamilton and Executive Chairman Patrick G. Ryan bought additional shares, while the company expanded its share repurchase program by US$300 million after using up its prior authorization. The combination of a legal probe, softer operating metrics and pricing headwinds, alongside fresh insider buying and a larger buyback, highlights a company facing business and legal questions while management signals confidence through capital deployment and personal share purchases. Investors can consider the potential impact of any future legal findings and ongoing margin pressure in the context of the board and executives’ decision to commit more capital to the stock.Recent Insider Transactions • Jun 08Founder & Executive Chairman recently bought US$3.9m worth of stockOn the 5th of June, Patrick Ryan bought around 120k shares on-market at roughly US$32.50 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Patrick's only on-market trade for the last 12 months.ナラティブ更新 • Jun 03RYAN: Expanded Buyback And AI Productivity Are Expected To Support EarningsRyan Specialty Holdings' updated analyst price target has shifted as analysts weigh a $2 change in Street targets, Ryan Specialty's expanded $300M buyback, and group wide revisions tied to slower premium growth and AI related concerns about broker disruption. Analyst Commentary Recent Street research around Ryan Specialty reflects a mix of caution on premium trends and AI related disruption, alongside a cluster of target changes that still frame the stock within an active rerating debate.Major Estimate Revision • May 11Consensus EPS estimates fall by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.36b to US$3.26b. EPS estimate also fell from US$1.00 per share to US$0.831 per share. Net income forecast to grow 162% next year vs 3.0% growth forecast for Insurance industry in the US. Consensus price target down from US$48.59 to US$42.88. Share price rose 5.6% to US$31.31 over the past week.Declared Dividend • May 04First quarter dividend of US$0.13 announcedShareholders will receive a dividend of US$0.13. Ex-date: 12th May 2026 Payment date: 26th May 2026 Dividend yield will be 1.6%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (25% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 185% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 02Ryan Specialty Holdings, Inc. announces Quarterly dividend, payable on May 26, 2026Ryan Specialty Holdings, Inc. announced Quarterly dividend of USD 0.1300 per share payable on May 26, 2026, ex-date on May 12, 2026 and record date on May 12, 2026.Reported Earnings • May 01First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2026 results: EPS: US$0.14 (up from US$0.22 loss in 1Q 2025). Revenue: US$795.2m (up 18% from 1Q 2025). Net income: US$40.6m (up US$68.2m from 1Q 2025). Profit margin: 5.1% (up from net loss in 1Q 2025). Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 14%. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 10% per year.ナラティブ更新 • Apr 29RYAN: AI Productivity And M&A Pipeline Are Expected To Sustain EarningsAnalysts have reduced the fair value estimate for Ryan Specialty Holdings from about $80.34 to $69.03. This reflects updated assumptions for slower revenue growth, slightly softer margins, and a modestly higher discount rate following a series of price target cuts across the Street.ナラティブ更新 • Apr 14RYAN: AI Risk Repricing Will Meet Capital Returns And M&A ExecutionRyan Specialty Holdings' analyst price target has been revised lower to $36 from $43, as analysts incorporate more cautious assumptions on revenue growth, profit margins, and future P/E multiples following a broad series of recent target cuts across the broker group. Analyst Commentary Recent research points to a clear shift toward more cautious assumptions on Ryan Specialty Holdings, with several firms trimming price targets and at least one downgrade reflecting concern around growth durability, margins, and valuation support.Price Target Changed • Apr 10Price target decreased by 7.3% to US$49.65Down from US$53.53, the current price target is an average from 17 analysts. New target price is 44% above last closing price of US$34.57. Stock is down 53% over the past year. The company is forecast to post earnings per share of US$1.00 for next year compared to US$0.50 last year.Major Estimate Revision • Apr 09Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.44b to US$3.39b. EPS estimate also fell from US$1.12 per share to US$1.01 per share. Net income forecast to grow 387% next year vs 3.7% growth forecast for Insurance industry in the US. Consensus price target down from US$53.53 to US$50.35. Share price rose 4.1% to US$34.89 over the past week.お知らせ • Apr 07Ryan Specialty Holdings, Inc. to Report Q1, 2026 Results on Apr 30, 2026Ryan Specialty Holdings, Inc. announced that they will report Q1, 2026 results After-Market on Apr 30, 2026ナラティブ更新 • Mar 31RYAN: AI Productivity And Capital Returns Will Support Future RepricingAnalysts have lowered price targets on Ryan Specialty Holdings by roughly $5 to $15 to reflect concerns about slower excess and surplus market growth and fears of AI-related disruption, even as some point to potential support from AI-driven productivity and margins that appear more resilient than recent trading suggests. Analyst Commentary Recent Street research on Ryan Specialty reflects a clear tilt toward more cautious views, with several firms cutting price targets and, in at least one case, lowering the stock rating.ナラティブ更新 • Mar 17RYAN: Core Brokerage Role Will Benefit From AI Productivity TailwindThe updated analyst price target for Ryan Specialty Holdings edges up to $55.25 from $54.88, as analysts weigh softer revenue growth assumptions against slightly higher margin expectations and a modestly lower future P/E. They are also factoring in recent sector wide target cuts tied to AI disruption concerns and excess and surplus market deceleration.ナラティブ更新 • Mar 03RYAN: Core Brokerage Role Will Withstand Softer P And C CycleAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings from about $66.53 to $54.88, reflecting lower Street price targets in the $43 to $65 range and updated expectations for slower revenue growth, softer profit margins, and a higher future P/E multiple. Analyst Commentary Recent Street research around Ryan Specialty Holdings has turned more cautious overall, with several firms cutting price targets and, in one case, lowering the rating.New Risk • Feb 25New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Payout ratio: 96% Dividend yield: 1.4% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Dividend is not well covered by earnings (96% payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).Recent Insider Transactions • Feb 25Director recently bought US$1.0m worth of stockOn the 23rd of February, Patrick Ryan bought around 26k shares on-market at roughly US$39.98 per share. This transaction amounted to 3.9% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold US$2.8m more in shares than they bought in the last 12 months.Major Estimate Revision • Feb 20Consensus EPS estimates increase by 11%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from US$3.58b to US$3.46b. EPS estimate rose from US$1.02 to US$1.12. Net income forecast to grow 428% next year vs 9.7% growth forecast for Insurance industry in the US. Consensus price target down from US$64.31 to US$57.25. Share price fell 6.9% to US$41.33 over the past week.ナラティブ更新 • Feb 17RYAN: Softening P&C Cycle And Capital Moves Will Shape Future RepricingAnalysts have trimmed the fair value estimate for Ryan Specialty Holdings to $43 from $52, reflecting updated views on slower revenue growth assumptions, slightly lower profit margins, and a reduced future P/E multiple across recent Street research. Analyst Commentary Recent Street research on Ryan Specialty Holdings has shifted in a more cautious direction, with several bearish analysts trimming price targets and highlighting potential pressure on growth, margins, and valuation multiples.New Risk • Feb 16New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 3.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).Declared Dividend • Feb 16Fourth quarter dividend increased to US$0.13Dividend of US$0.13 is 8.3% higher than last year. Ex-date: 24th February 2026 Payment date: 10th March 2026 Dividend yield will be 1.3%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is not adequately covered by earnings (96% earnings payout ratio). However, it is well covered by cash flows (24% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 2 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 7.1% to bring the payout ratio under control. EPS is expected to grow by 173% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.New Risk • Feb 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results.Price Target Changed • Feb 13Price target decreased by 10.0% to US$58.25Down from US$64.69, the current price target is an average from 16 analysts. New target price is 50% above last closing price of US$38.71. Stock is down 44% over the past year. The company is forecast to post earnings per share of US$0.83 for next year compared to US$0.50 last year.お知らせ • Feb 13+ 2 more updatesRyan Specialty Holdings, Inc., Annual General Meeting, Apr 28, 2026Ryan Specialty Holdings, Inc., Annual General Meeting, Apr 28, 2026.お知らせ • Feb 05Ryan Specialty Appoints Stephen Stewart as CEO of Ryan Specialty Canada LimitedRyan Specialty announced the appointment of Stephen Stewart, President & CEO of Stewart Specialty Risk Underwriting, a Ryan Specialty managing general underwriter, to the additional role Chief Executive Officer of Ryan Specialty Canada Limited, the newly formed Canadian operating and holding entity for Ryan Specialty’s underwriting management businesses in Canada. Ryan Specialty Canada Limited is headquartered in Toronto. In Stephen Stewart’s additional role as CEO of Ryan Specialty Canada Limited, he will lead the continued growth of Ryan Specialty’s Canadian platform while maintaining the underwriting discipline and specialist focus that have defined Stewart Specialty Risk Underwriting and Ryan Specialty’s other Canadian units. The legal integration is already underway, and teams are actively engaging with new colleagues across underwriting, operations, and support functions to build a unified Canadian platform.ナラティブ更新 • Feb 03RYAN: Double Digit Organic Expansion Is Expected To Sustain Earnings Through Softer P&C CycleAnalysts now estimate Ryan Specialty Holdings' fair value at about $80.34, up from $76.00. This change reflects updated assumptions for slower revenue growth, lower profit margins, and a higher future P/E multiple across recent P&C insurance sector research.ナラティブ更新 • Jan 19RYAN: Softening P&C Cycle And Governance Shift Will Shape Future Share RepricingAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings to $52 from $58, reflecting a lower future P/E assumption, while updated models still factor in steady revenue growth and margins across a softening property and casualty cycle. Analyst Commentary Recent Street research on Ryan Specialty presents a mixed picture, with several firms trimming price targets even as some maintain positive ratings.お知らせ • Jan 13Ryan Specialty Holdings, Inc. to Report Q4, 2025 Results on Feb 12, 2026Ryan Specialty Holdings, Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 12, 2026ナラティブ更新 • Jan 05RYAN: Double Digit Organic Expansion Outlook Will Drive Future Share RepricingAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings to $58 from $60, reflecting updated views on revenue growth potential, profit margins, and a lower future P/E multiple after a mix of recent target cuts and raises across the Street. Analyst Commentary Recent Street research on Ryan Specialty Holdings shows a mix of optimism on the business model and caution on how much investors should be willing to pay for the stock.ナラティブ更新 • Dec 18RYAN: Double Digit Organic Expansion Is Expected To Drive Strong Earnings AheadAnalysts have trimmed their price target for Ryan Specialty Holdings to $76 from $90, reflecting a modestly higher discount rate and more measured revenue growth expectations, even as they highlight resilient profit margins, double digit organic growth prospects into 2025 and 2026, and a still supportive earnings backdrop for property and casualty insurers. Analyst Commentary Bullish analysts acknowledge a reset in valuation assumptions but continue to frame Ryan Specialty as a long term compounder, citing durable organic growth, expanding distribution, and a supportive earnings environment for specialty focused intermediaries.Recent Insider Transactions Derivative • Dec 16CEO & Director exercised options and sold US$6.9m worth of stockOn the 12th of December, Timothy Turner exercised options to acquire 130k shares at no cost and sold these for an average price of US$53.61 per share. This trade did not impact their existing holding. For the year to December 2020, Timothy's total compensation was 20% salary and 80% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Timothy's direct individual holding has increased from 8.10k shares to 12.55k. Company insiders have collectively sold US$46m more than they bought, via options and on-market transactions in the last 12 months.お知らせ • Dec 09+ 1 more updateRyan Specialty Holdings, Inc. Announces Retirement of Bobby Le Blanc from Board of Directors, Effective February 11, 2026Ryan Specialty Holdings, Inc. announced that by mutual agreement following Onex Corporation’s sale of its remaining shares of Ryan Specialty, Bobby Le Blanc will retire from his service on the Ryan Specialty Board of Directors effective February 11, 2026. Mr. Le Blanc, Onex’ CEO, has served on Ryan Specialty’s Board since 2018, originally as Onex’ nominee with its investment in Ryan Specialty. Bobby Le Blanc contributed significantly to Ryan Specialty's growth and market leadership in specialty insurance solutions during his tenure on the board.ナラティブ更新 • Dec 04RYAN: Double Digit Organic Expansion Will Outlast Softening Property And Casualty CycleAnalysts have trimmed their average price target on Ryan Specialty Holdings by about $2 to roughly $66.50. This reflects slightly lower assumptions for growth and margins amid softening property and casualty pricing, even as they continue to highlight the company's double digit organic revenue prospects and generally favorable long term earnings outlook.ナラティブ更新 • Nov 20RYAN: Earnings Strength Will Overcome Sector Headwinds Into 2025Ryan Specialty Holdings' analyst price target saw a modest increase to $68.46, reflecting analyst expectations for slightly improved revenue growth and profit margins in light of resilient earnings and favorable industry conditions. Analyst Commentary Recent analyst coverage of Ryan Specialty Holdings reflects a nuanced perspective, with sentiment split between optimism about the firm's growth prospects and caution stemming from broader sector challenges.New Risk • Nov 07New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.1% Last year net profit margin: 4.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.1% net profit margin).Major Estimate Revision • Nov 06Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.69 to US$0.766. Revenue forecast steady at US$3.08b. Net income forecast to grow 319% next year vs 9.9% growth forecast for Insurance industry in the US. Consensus price target down from US$72.00 to US$68.31. Share price rose 12% to US$56.94 over the past week.ナラティブ更新 • Nov 05RYAN: Ongoing Earnings Resilience And Sector Demand Will Drive Upside MomentumThe average analyst price target for Ryan Specialty Holdings has been revised downward by approximately $3.69 to $68.31. This reflects more cautious near-term assumptions on margin and sector growth trends, despite ongoing buy ratings and optimism around resilient earnings and organic growth.分析記事 • Nov 03Ryan Specialty Holdings (NYSE:RYAN) Is Paying Out A Dividend Of $0.12The board of Ryan Specialty Holdings, Inc. ( NYSE:RYAN ) has announced that it will pay a dividend on the 25th of...Declared Dividend • Nov 03Third quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 10th November 2025 Payment date: 25th November 2025 Dividend yield will be 0.9%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (16% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 148% over the next 2 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Oct 31Third quarter 2025 earnings: EPS in line with analyst expectations despite revenue beatThird quarter 2025 results: EPS: US$0.49 (up from US$0.15 in 3Q 2024). Revenue: US$754.6m (up 28% from 3Q 2024). Net income: US$62.6m (up 249% from 3Q 2024). Profit margin: 8.3% (up from 3.1% in 3Q 2024). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 31+ 1 more updateRyan Specialty Holdings, Inc. Declares A Regular Quarterly Dividend, Payable on November 25, 2025On October 30, 2025, Ryan Specialty Holdings, Inc.’s board of directors declared a regular quarterly dividend of $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on November 25, 2025, to stockholders of record as of the close of business on November 11, 2025.ナラティブ更新 • Oct 22Analysts Weigh Resilient Margins and Growth Outlook for Ryan Specialty Holdings Amid Valuation ShiftsAnalysts have slightly lowered their average price target for Ryan Specialty Holdings, noting resilient profit margins and earnings support from lighter catastrophe losses even as the sector faces growth headwinds. Analyst Commentary Recent Street research on Ryan Specialty Holdings highlights a mix of optimism and caution, reflecting varying outlooks for the company as growth moderates in the broader insurance sector.Major Estimate Revision • Oct 09Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.622 to US$0.693. Revenue forecast steady at US$3.07b. Net income forecast to grow 543% next year vs 13% growth forecast for Insurance industry in the US. Consensus price target broadly unchanged at US$71.85. Share price was steady at US$55.63 over the past week.お知らせ • Oct 09Ryan Specialty Holdings, Inc. Announces Executive ChangesOn October 8, 2025, the Board of Directors of Ryan Specialty Holdings, Inc. (the Company" or Ryan Specialty") appointed Stephen P. Keogh as Co-President and Chief Operating Officer and Brendan M. Mulshine as Co-President and Chief Revenue Officer of the Company to succeed Jeremiah Bickham as President, effective October 9, 2025. Stephen P. Keogh, age 59, has served as the Company's Chief Operating Officer since May 2025. Previously, Mr. Keogh was the Senior Advisor to the Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that, commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management business of Aon. Mr. Keogh holds in excess of thirty-two years of experience at Aon, where he held positions in operations, finance and accounting, technology, human resources and executive management. Mr. Keogh earned a Bachelor's degree from the University of Illinois. Brendan M. Mulshine, age 59, has served as the Company's Executive Vice President and Chief Revenue Officer since 2020 and previously served as the Company's Executive Vice President and Managing Director from 2012 through 2020. From 1995 to 2012, Mr. Mulshine held various leadership positions at Aon Re, working with domestic and global insurance company clients on their reinsurance capital needs. Mr. Mulshine began his career practicing law in New York City. He earned a Bachelor of Arts from Yale College, a Juris Doctor from the University of Notre Dame School of Law, and a Master of Business Administration from Northwestern University's Kellogg School of Management. Changes to Messrs. On October 2, 2025, the Company and Mr. Jeremiah Bickham agreed that, effective October 8, 2025, Mr. Bickham would be transitioning from his role as President to serve as a non-employee strategic advisor to the Company through January 1, 2026.ナラティブ更新 • Oct 08Emerging Risks And Data Analytics Will Expand Future OpportunitiesAnalysts have modestly reduced their price target for Ryan Specialty Holdings, citing commercial property growth headwinds and a slight decrease in projected revenue growth. The fair value estimate is now lowered by approximately $1.42 to $72.00 per share.お知らせ • Oct 03Ryan Specialty Holdings, Inc. to Report Q3, 2025 Results on Oct 30, 2025Ryan Specialty Holdings, Inc. announced that they will report Q3, 2025 results After-Market on Oct 30, 2025お知らせ • Sep 10Ryan Specialty Holdings, Inc. Appoints Michael G. Bungert to Its Board of Directors and Serves as A Member of Its Compensation and Governance Committee, Effective September 3, 2025Ryan Specialty Holdings, Inc. on September 3, 2025 elected Michael G. Bungert as a director and assigned him to its Compensation and Governance Committee, effective September 9, 2025. Mr. Bungert's initial term as a director will expire at the 2026 annual meeting of the Company's stockholders, at which time his continued Board service will be subject to renomination and stockholder approval. There are no transactions in which Mr. Bungert has or will have an interest that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K under the Exchange Act, at this time. The selection of Mr. Bungert was not pursuant to any arrangement or understanding between him and any other person. Mr. Bungert will participate in the Company's standard non-employee director compensation arrangements. Mr. Bungert will receive a grant of restricted stock units (RSUs) with a grant date fair value equal to $200,000 (prorated for the portion of the year for which he served as a director) that fully vest on the grant date and each RSU represents a right to receive one fully vested share of the Company's Class A common stock. The Company will make the annual equity grant of RSUs on the date of the Company's next annual meeting of stockholders and such grant will be compensation for the prior year of service, or portion thereof. Additionally, Mr. Bungert will be entitled to receive a cash payment in the amount of $120,000 per year, paid quarterly, in respect of his service as a member of the Board, with no additional cash compensation paid on account of his service on the Compensation and Governance Committee. Mr. Bungert has had a long and illustrious reinsurance career, most recently as Chairman of Aon Re Global from which he retired in 2024 after 11 years in that position. Prior to being Chairman, Mr. Bungert was CEO of Aon Re, a position he assumed in 1998. Mr. Bungert started his career in reinsurance in 1977 as an underwriter trainee at Continental Casualty Company. He then joined CNA Re in 1979 as a London-based North American underwriter. In 1984, Mr. Bungert joined reinsurance intermediary Thomas A. Greene Inc. Intermediaries in Chicago and subsequently joined Aon Re in 1989.ナラティブ更新 • Sep 04Emerging Risks And Data Analytics Will Expand Future OpportunitiesAmid increased competition in personal auto, softened reinsurance pricing, and pressure on underwriting margins for carriers, analysts have adopted a more cautious outlook for the sector—though brokers like Ryan Specialty are expected to demonstrate relative earnings resilience—with the consensus price target remaining unchanged at $73.42. Analyst Commentary Increased competition in the personal auto insurance market and softened reinsurance pricing, resulting in a more cautious outlook and modest reductions of price targets.Major Estimate Revision • Aug 07Consensus EPS estimates fall by 14%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$0.853 to US$0.733 per share. Revenue forecast steady at US$3.08b. Net income forecast to grow 571% next year vs 11% growth forecast for Insurance industry in the US. Consensus price target down from US$78.00 to US$75.60. Share price fell 2.7% to US$59.55 over the past week.Declared Dividend • Aug 04Second quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 12th August 2025 Payment date: 26th August 2025 Dividend yield will be 0.8%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is not covered by earnings (233% earnings payout ratio). However, it is well covered by cash flows (25% cash payout ratio). The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years. The company's earnings per share (EPS) would need to grow by 159% to bring the payout ratio under control. EPS is expected to grow by 418% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.Reported Earnings • Aug 01Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2025 results: EPS: US$0.41 (up from US$0.38 in 2Q 2024). Revenue: US$855.2m (up 26% from 2Q 2024). Net income: US$124.7m (up 176% from 2Q 2024). Profit margin: 15% (up from 6.6% in 2Q 2024). Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) missed analyst estimates by 1.9%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 01+ 1 more updateRyan Specialty Holdings, Inc. Updates Earnings Guidance for the Full Year 2025Ryan Specialty Holdings, Inc. updated earnings guidance for the full year 2025. Organic Revenue Growth Rate guidance for full year 2025 is between 9.0% – 11.0%, compared to the company’s prior guidance of 11% – 13.0%.お知らせ • Jul 18Ryan Specialty Holdings, Inc. Announces Board and Committee ChangesRyan Specialty Holdings, Inc. shared the sad news of the loss of Director, D. Cameron (“Cam”) Findlay, who unexpectedly passed away earlier this month. Mr. Findlay served on the Ryan Specialty Board, including its pre-IPO predecessor, since 2012, and was most recently the chairperson of the Compensation and Governance Committee, a member of the Executive Committee, and the Board’s Lead Director. From 2013 until his retirement in 2023, Mr. Findlay was the Senior Vice President, General Counsel, and Secretary of Archer Daniels Midland Company. From 2009 to 2013, he was Senior Vice President and General Counsel of Medtronic, Inc., and from 2003 to 2009 he served as Executive Vice President and General Counsel of Aon Corporation. In addition to his time as a lawyer and businessperson, Mr. Findlay had a distinguished career in government service, including at the White House as deputy assistant to President George H.W. Bush, at the U.S. Department of Labor as the deputy secretary of labor, at the U.S. Supreme Court as a law clerk for Justice Antonin Scalia, and at the U.S. Court of Appeals for the D.C. Circuit as a law clerk for Judge Stephen F. Williams. He earned his B.A. from Northwestern University, his Master of Arts (Oxon.) from Oxford University, and his Juris Doctor from Harvard Law School. On July 16, 2025, the Board appointed John W. Rogers, Jr. as Lead Director and Henry S. Bienen as Chairperson of the Compensation and Governance Committee.お知らせ • Jul 15Ryan Specialty Holdings, Inc. to Report Q2, 2025 Results on Jul 31, 2025Ryan Specialty Holdings, Inc. announced that they will report Q2, 2025 results After-Market on Jul 31, 2025お知らせ • Jul 02Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of JM Wilson Corporation.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire JM Wilson Corporation on June 5, 2025. JM Wilson is based in Michigan and its operations will become a part of RT Binding Authority, the binding authority specialty of Ryan Specialty.JM Wilson generated approximately $19 million of operating revenue for the 12 months ended January 31, 2025. The transaction is expected to close in the third quarter of 2025. Philo Smith & Co. acted as financial advisor for JM Wilson Corporation. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of JM Wilson Corporation on July 1, 2025.Recent Insider Transactions • May 20President recently sold US$3.5m worth of stockOn the 16th of May, Jeremiah Bickham sold around 50k shares on-market at roughly US$70.09 per share. This transaction amounted to 96% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Jeremiah's only on-market trade for the last 12 months.Major Estimate Revision • May 09Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$1.12 to US$0.858 per share. Revenue forecast steady at US$3.08b. Net income forecast to grow 524% next year vs 12% growth forecast for Insurance industry in the US. Consensus price target of US$75.90 unchanged from last update. Share price rose 8.2% to US$70.13 over the past week.Declared Dividend • May 05First quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 13th May 2025 Payment date: 27th May 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 108%. Cash payout ratio: 29%.New Risk • May 02New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.9% Last year net profit margin: 3.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin).Reported Earnings • May 02First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2025 results: US$0.22 loss per share (down from US$0.14 profit in 1Q 2024). Revenue: US$690.2m (up 28% from 1Q 2024). Net loss: US$4.39m (down 127% from profit in 1Q 2024). Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.お知らせ • May 02+ 1 more updateRyan Specialty Holdings, Inc. Declares Regular Quarterly Dividend, Payable on May 27, 2025On May 1, 2025, the board of directors of Ryan Specialty Holdings, Inc. declared a regular quarterly dividend of $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on May 27, 2025 to stockholders of record as of the close of business on May 13, 2025. A portion of the dividend, $0.05 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company's Class A common stock and the holders of the LLC Common Units.お知らせ • Apr 07Ryan Specialty Holdings, Inc., Annual General Meeting, May 30, 2025Ryan Specialty Holdings, Inc., Annual General Meeting, May 30, 2025.お知らせ • Apr 04Ryan Specialty Holdings, Inc. to Report Q1, 2025 Results on May 01, 2025Ryan Specialty Holdings, Inc. announced that they will report Q1, 2025 results After-Market on May 01, 2025お知らせ • Mar 28Ryan Specialty Holdings, Inc. Appoints Stephen P. Keogh as Chief Operating Officer, Effective May 1, 2025On March 27, 2025, Ryan Specialty Holdings, Inc. announced the appointment of Mr. Stephen P. Keogh to the position of Chief Operating Officer of the Company, effective May 1, 2025. Stephen P. Keogh, age 58, was most recently Senior Advisor to the Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that, commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management business of Aon. Mr. Keogh brings in excess of thirty- two years of experience at Aon, where he held positions in operations, finance and accounting, technology, human resources and executive management. Mr. Keogh is a member of the Board of Trustees of the Illinois Institute of Chicago and earned a Bachelor’s degree from the University of Illinois.Recent Insider Transactions Derivative • Mar 18Executive VP & Chief Revenue Officer exercised options and sold US$2.1m worth of stockOn the 14th of March, Brendan Mulshine exercised options to acquire 30k shares at no cost and sold these for an average price of US$69.30 per share. This trade did not impact their existing holding. Since June 2024, Brendan's direct individual holding has decreased from 76.50k shares to 75.82k. Company insiders have collectively sold US$179m more than they bought, via options and on-market transactions in the last 12 months.Major Estimate Revision • Feb 28Consensus EPS estimates fall by 12%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from US$3.02b to US$3.05b. EPS estimate fell from US$1.44 to US$1.27 per share. Net income forecast to grow 212% next year vs 9.4% growth forecast for Insurance industry in the US. Consensus price target broadly unchanged at US$75.60. Share price rose 2.1% to US$70.03 over the past week.Declared Dividend • Feb 25Fourth quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 4th March 2025 Payment date: 18th March 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 56%. Cash payout ratio: 27%.New Risk • Feb 24New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 33% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Significant insider selling over the past 3 months (US$34m sold).お知らせ • Feb 21+ 1 more updateRyan Specialty Holdings, Inc. Declares Regular Quarterly Dividend on Outstanding Class A Common Stock, Payable on March 18, 2025On February 20, 2025, Ryan Specialty Holdings, Inc. declared and increased the Company's regular quarterly dividend by 9.1% to $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on March 18, 2025 to stockholders of record as of the close of business on March 4, 2025. A portion of the dividend, $0.05 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company's Class A common stock and the holders of the LLC Common Units.お知らせ • Feb 04Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others for approximately $530 million on January 7, 2025. The upfront cash consideration is exclusive of VSIC and any earnout consideration. Velocity generated approximately $81 million of operating revenue for the 12 months ended December 31, 2024. The acquisition of Velocity is expected to close in early 2025. Andrew Jamieson of Debevoise & Plimpton LLP acted as legal advisor to Oaktree and Velocity Risk. Howden Tiger Capital Markets & Advisory, LLC acted as financial advisor to Oaktree and Velocity Risk. Insurance Advisory Partners LLC acted as financial advisor to Oaktree and Velocity Risk. Sidley Austin LLP acted as legal advisor to Ryan Specialty. J.P. Morgan Securities LLC acted as financial advisor to Ryan Specialty. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others on February 3, 2025.Recent Insider Transactions • Jan 16Director recently sold US$6.5m worth of stockOn the 15th of January, Nicholas Cortezi sold around 99k shares on-market at roughly US$65.50 per share. This transaction amounted to 28% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth US$7.0m. Insiders have been net sellers, collectively disposing of US$25m more than they bought in the last 12 months.お知らせ • Jan 10Ryan Specialty Holdings, Inc. to Report Q4, 2024 Results on Feb 20, 2025Ryan Specialty Holdings, Inc. announced that they will report Q4, 2024 results After-Market on Feb 20, 2025株主還元RYANUS InsuranceUS 市場7D0.5%-0.8%-2.1%1Y-28.1%3.0%18.8%株主還元を見る業界別リターン: RYAN過去 1 年間で3 % の収益を上げたUS Insurance業界を下回りました。リターン対市場: RYANは、過去 1 年間で18.8 % のリターンを上げたUS市場を下回りました。価格変動Is RYAN's price volatile compared to industry and market?RYAN volatilityRYAN Average Weekly Movement6.5%Insurance Industry Average Movement4.7%Market Average Movement7.2%10% most volatile stocks in US Market16.3%10% least volatile stocks in US Market3.1%安定した株価: RYAN 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: RYANの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20106,171Tim Turnerwww.ryanspecialty.comライアン・スペシャルティ・ホールディングスは、米国、カナダ、英国、その他の欧州諸国、インド、シンガポール、および国際的な保険ブローカー、代理店、保険会社向けに特殊商品やソリューションを提供するサービス・プロバイダーとして事業を展開している。同社は、ホールセール・ブローカーとして、また保険会社から権限を委譲されたマネージング・アンダーライターまたはプログラム・アドミニストレーターとして、販売、引受、商品開発、管理、リスク管理サービスを提供している。商業、産業、機関、個人、政府部門にサービスを提供している。同社は2010年に設立され、イリノイ州シカゴに本社を置いている。もっと見るRyan Specialty Holdings, Inc. 基礎のまとめRyan Specialty Holdings の収益と売上を時価総額と比較するとどうか。RYAN 基礎統計学時価総額US$10.80b収益（TTM）US$99.03m売上高(TTM)US$3.16b53.1xPER（株価収益率1.7xP/SレシオRYAN は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計RYAN 損益計算書（TTM）収益US$3.16b売上原価US$1.85b売上総利益US$1.31bその他の費用US$1.21b収益US$99.03m直近の収益報告Jun 30, 2026次回決算日該当なし一株当たり利益（EPS）0.81グロス・マージン41.49%純利益率3.13%有利子負債／自己資本比率357.5%RYAN の長期的なパフォーマンスは？過去の実績と比較を見る配当金1.2%現在の配当利回り65%配当性向RYAN 配当は確実ですか？RYAN 配当履歴とベンチマークを見るRYAN 、いつまでに購入すれば配当金を受け取れますか？Ryan Specialty Holdings 配当日配当落ち日Aug 11 2026配当支払日Aug 25 2026配当落ちまでの日数10 days配当支払日までの日数4 daysRYAN 配当は確実ですか？RYAN 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/20 07:20終値2026/08/20 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ryan Specialty Holdings, Inc. 16 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。24 アナリスト機関Tracy Dolin-BenguiguiBarclaysTaylor ScottBarclaysMichael ZaremskiBMO Capital Markets Equity Research21 その他のアナリストを表示
ナラティブ更新 • Aug 13RYAN: Share Repurchases Will Support Q2 Momentum Through Softer Pricing CycleAnalysts recently lifted the fair value estimate for Ryan Specialty Holdings from $45.88 to $50.72, reflecting higher Street price targets in the $39 to $69 range and updated assumptions for slightly stronger revenue growth, wider profit margins and a lower future P/E multiple. Analyst Commentary Recent research on Ryan Specialty Holdings shows a mix of optimism and caution, with many firms adjusting price targets higher while still debating the durability of growth and the right valuation level for the stock.
Reported Earnings • Jul 31Second quarter 2026 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2026 results: EPS: US$0.34 (down from US$0.41 in 2Q 2025). Revenue: US$916.6m (up 9.0% from 2Q 2025). Net income: US$42.3m (down 19% from 2Q 2025). Profit margin: 4.6% (down from 6.2% in 2Q 2025). Revenue exceeded analyst estimates by 5.4%. Earnings per share (EPS) also surpassed analyst estimates by 3.9%. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year.
お知らせ • Jul 31Ryan Specialty Holdings, Inc. Declares Quarterly Dividend on the Outstanding Class A Common Stock, Payable on August 25, 2026On July 30, 2026, Ryan Specialty Holdings, Inc.'s board of directors declared a quarterly dividend of $0.13 per share on the outstanding Class A common stock. The quarterly dividend will be payable on August 25, 2026, to stockholders of record as of the close of business on August 11, 2026.
ナラティブ更新 • Jul 30RYAN: Softer Pricing And Buybacks Will Offset Catastrophe And Cycle RisksRyan Specialty Holdings' analyst fair value estimate has been revised higher to $45.88 from $43.29 as analysts factor in updated price targets across the Street, along with a mix of views on how soft commercial pricing, catastrophe exposure and recent buyback activity could influence growth, profitability and future P/E assumptions. Analyst Commentary Recent Street research on Ryan Specialty Holdings shows a mix of optimism and caution around growth, execution and valuation as commercial pricing softens and catastrophe trends remain a focus.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to US$46.48, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 12x in the Insurance industry in the US. Total returns to shareholders of 8.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$22.72 per share.
ナラティブ更新 • Jul 16RYAN: Prolonged P&C Price Softening Will Challenge Execution Against Growth ExpectationsAnalysts trimmed the Ryan Specialty fair value estimate to $34 from $36, reflecting slightly higher discount rate assumptions and more cautious views on revenue growth, profit margins, and future P/E in light of recent mixed shifts in Street price targets across the insurance broker group. Analyst Commentary Street research on Ryan Specialty Holdings shows a mixed backdrop, with several price target raises alongside more cautious views on growth, valuation, and the commercial property and casualty cycle.
ナラティブ更新 • Aug 13RYAN: Share Repurchases Will Support Q2 Momentum Through Softer Pricing CycleAnalysts recently lifted the fair value estimate for Ryan Specialty Holdings from $45.88 to $50.72, reflecting higher Street price targets in the $39 to $69 range and updated assumptions for slightly stronger revenue growth, wider profit margins and a lower future P/E multiple. Analyst Commentary Recent research on Ryan Specialty Holdings shows a mix of optimism and caution, with many firms adjusting price targets higher while still debating the durability of growth and the right valuation level for the stock.
Reported Earnings • Jul 31Second quarter 2026 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2026 results: EPS: US$0.34 (down from US$0.41 in 2Q 2025). Revenue: US$916.6m (up 9.0% from 2Q 2025). Net income: US$42.3m (down 19% from 2Q 2025). Profit margin: 4.6% (down from 6.2% in 2Q 2025). Revenue exceeded analyst estimates by 5.4%. Earnings per share (EPS) also surpassed analyst estimates by 3.9%. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year.
お知らせ • Jul 31Ryan Specialty Holdings, Inc. Declares Quarterly Dividend on the Outstanding Class A Common Stock, Payable on August 25, 2026On July 30, 2026, Ryan Specialty Holdings, Inc.'s board of directors declared a quarterly dividend of $0.13 per share on the outstanding Class A common stock. The quarterly dividend will be payable on August 25, 2026, to stockholders of record as of the close of business on August 11, 2026.
ナラティブ更新 • Jul 30RYAN: Softer Pricing And Buybacks Will Offset Catastrophe And Cycle RisksRyan Specialty Holdings' analyst fair value estimate has been revised higher to $45.88 from $43.29 as analysts factor in updated price targets across the Street, along with a mix of views on how soft commercial pricing, catastrophe exposure and recent buyback activity could influence growth, profitability and future P/E assumptions. Analyst Commentary Recent Street research on Ryan Specialty Holdings shows a mix of optimism and caution around growth, execution and valuation as commercial pricing softens and catastrophe trends remain a focus.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to US$46.48, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 12x in the Insurance industry in the US. Total returns to shareholders of 8.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$22.72 per share.
ナラティブ更新 • Jul 16RYAN: Prolonged P&C Price Softening Will Challenge Execution Against Growth ExpectationsAnalysts trimmed the Ryan Specialty fair value estimate to $34 from $36, reflecting slightly higher discount rate assumptions and more cautious views on revenue growth, profit margins, and future P/E in light of recent mixed shifts in Street price targets across the insurance broker group. Analyst Commentary Street research on Ryan Specialty Holdings shows a mixed backdrop, with several price target raises alongside more cautious views on growth, valuation, and the commercial property and casualty cycle.
ライブニュース • Jul 15Ryan Specialty Launches Renewables Unit and Names Jeff Smith as CEORyan Specialty Holdings has created Ryan Specialty Renewables as a unified managing general underwriting platform for renewable and energy transition solutions and appointed Jeff Smith as CEO. The rebranding of PERse North America, PERse International and Albus is expected to be completed in Q3 2026. The consolidation brings the company’s existing renewable-focused MGUs under one global platform aimed at offering a broad set of insurance products and services to middle-market and large renewable energy clients. Ryan Specialty’s stock trades at US$40.66, with the share price down 19.7% year to date, while this renewables build-out is being put in place. The new Ryan Specialty Renewables unit concentrates the group’s expertise in one area, which could sharpen its offering to large renewable energy projects but also increases the company’s exposure to a specialized segment that can be competitive and reliant on project volumes.
ライブニュース • Jul 06Ryan Specialty Secures Lloyd’s Consortium Support for Global Underwriting PortfolioRyan Specialty Underwriting Managers has completed a series of Lloyd’s of London consortium stamps backed by six leading syndicates, which will take a combined 15% share of its global syndicated property and casualty delegated underwriting portfolio across all classes and geographies, excluding Velocity Risk Underwriters, starting at natural renewals from 1 August 2026. These consortium stamps expand access to Lloyd’s capital for Ryan Specialty’s delegated underwriting platform, directly affecting how risk is syndicated and potentially supporting the scale and breadth of its global property and casualty facilities. Ryan Specialty Holdings’ stock trades at $42.03, with the share price up 29.1% over the past 30 days. This Lloyd’s-backed capacity arrangement gives Ryan Specialty clearer visibility on future underwriting support for its delegated portfolio, but investors will still need to watch how the 15% allocation is utilized across classes and geographies, and how it affects underwriting results once the facilities renew from 2026 onward.
お知らせ • Jul 04Ryan Specialty Holdings, Inc. to Report Q2, 2026 Results on Jul 30, 2026Ryan Specialty Holdings, Inc. announced that they will report Q2, 2026 results After-Market on Jul 30, 2026
ナラティブ更新 • Jul 01RYAN: Softer Pricing And Buybacks Will Shape Earnings Resilience OutlookAnalysts have reset the fair value estimate for Ryan Specialty Holdings to $43.29 from $55.25. This reflects a series of revised price targets around $39 to $44 as they factor in softer commercial property and casualty pricing alongside resilient earnings and margins.
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$38.88, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 10% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$25.51 per share.
ライブニュース • Jun 25RT Specialty Sets CEO Succession as Mulshine to Succeed McCormack in 2026Ryan Specialty’s wholesale arm RT Specialty announced a leadership succession plan effective August 1, 2026, with current CEO Ed McCormack moving to Vice Chairman through 2027 and Co-President of Ryan Specialty Brendan Mulshine set to become CEO of RT Specialty. The planned transition involves a core business within Ryan Specialty and places Mulshine in charge of leading growth initiatives and deepening client and carrier relationships, while keeping McCormack involved at the board level. Ryan Specialty shares trade at US$35.28, with the stock down 30.3% year to date, putting extra focus on how leadership changes at RT Specialty align with execution across the broader group. A clearly flagged succession timeline gives you more visibility on leadership continuity at Ryan Specialty, but it also concentrates attention on execution risk around 2026 and 2027 as Mulshine steps into a key operating role.
ナラティブ更新 • Jun 17RYAN: Expanded Buyback And Insider Buying Will Support Future Share PriceThe analyst price target for Ryan Specialty Holdings has narrowed slightly to align with a mix of recent cuts and one increase across the Street, reflecting concerns about softer commercial property and casualty pricing, alongside support from the expanded $300M share buyback program. Analyst Commentary Recent research on Ryan Specialty Holdings shows a split view, with some firms trimming expectations around commercial property and casualty trends while others point to shareholder returns and execution as support for the stock.
ライブニュース • Jun 17Ryan Specialty Stock Gains Insider Support With $300M Buyback After 50% DeclineRyan Specialty insiders, including the CFO and two directors, recently bought shares in open-market transactions totaling more than US$560,000, increasing their personal stakes in the company. The company expanded its stock repurchase program by US$300m after using up its previous authorization. Ryan Specialty reported first-quarter revenue growth of 15.2% year over year and guided to mid-single-digit revenue growth. Insider purchases combined with a larger buyback program indicate that company leadership is willing to commit capital to Ryan Specialty stock, even after a share price decline of more than 50% over the past year. At the same time, investors may want to weigh this indication of confidence against concerns raised around operating margins and cash burn, as well as the mixed analyst views noted in recent research.
ライブニュース • Jun 09Ryan Specialty Holdings Faces Legal Scrutiny as Executives Increase Share Purchases and Buyback ProgramThe Schall Law Firm has opened an investigation into Ryan Specialty Holdings over potential securities law violations tied to alleged false or misleading disclosures and material omissions. The investigation follows the company’s Q4 and full-year 2025 results, after which the stock fell sharply as investors reacted to weaker organic revenue growth, margin pressure and challenging property pricing trends. Around the same time, CFO Janice M Hamilton and Executive Chairman Patrick G. Ryan bought additional shares, while the company expanded its share repurchase program by US$300 million after using up its prior authorization. The combination of a legal probe, softer operating metrics and pricing headwinds, alongside fresh insider buying and a larger buyback, highlights a company facing business and legal questions while management signals confidence through capital deployment and personal share purchases. Investors can consider the potential impact of any future legal findings and ongoing margin pressure in the context of the board and executives’ decision to commit more capital to the stock.
Recent Insider Transactions • Jun 08Founder & Executive Chairman recently bought US$3.9m worth of stockOn the 5th of June, Patrick Ryan bought around 120k shares on-market at roughly US$32.50 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Patrick's only on-market trade for the last 12 months.
ナラティブ更新 • Jun 03RYAN: Expanded Buyback And AI Productivity Are Expected To Support EarningsRyan Specialty Holdings' updated analyst price target has shifted as analysts weigh a $2 change in Street targets, Ryan Specialty's expanded $300M buyback, and group wide revisions tied to slower premium growth and AI related concerns about broker disruption. Analyst Commentary Recent Street research around Ryan Specialty reflects a mix of caution on premium trends and AI related disruption, alongside a cluster of target changes that still frame the stock within an active rerating debate.
Major Estimate Revision • May 11Consensus EPS estimates fall by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.36b to US$3.26b. EPS estimate also fell from US$1.00 per share to US$0.831 per share. Net income forecast to grow 162% next year vs 3.0% growth forecast for Insurance industry in the US. Consensus price target down from US$48.59 to US$42.88. Share price rose 5.6% to US$31.31 over the past week.
Declared Dividend • May 04First quarter dividend of US$0.13 announcedShareholders will receive a dividend of US$0.13. Ex-date: 12th May 2026 Payment date: 26th May 2026 Dividend yield will be 1.6%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (25% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 185% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 02Ryan Specialty Holdings, Inc. announces Quarterly dividend, payable on May 26, 2026Ryan Specialty Holdings, Inc. announced Quarterly dividend of USD 0.1300 per share payable on May 26, 2026, ex-date on May 12, 2026 and record date on May 12, 2026.
Reported Earnings • May 01First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2026 results: EPS: US$0.14 (up from US$0.22 loss in 1Q 2025). Revenue: US$795.2m (up 18% from 1Q 2025). Net income: US$40.6m (up US$68.2m from 1Q 2025). Profit margin: 5.1% (up from net loss in 1Q 2025). Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 14%. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 10% per year.
ナラティブ更新 • Apr 29RYAN: AI Productivity And M&A Pipeline Are Expected To Sustain EarningsAnalysts have reduced the fair value estimate for Ryan Specialty Holdings from about $80.34 to $69.03. This reflects updated assumptions for slower revenue growth, slightly softer margins, and a modestly higher discount rate following a series of price target cuts across the Street.
ナラティブ更新 • Apr 14RYAN: AI Risk Repricing Will Meet Capital Returns And M&A ExecutionRyan Specialty Holdings' analyst price target has been revised lower to $36 from $43, as analysts incorporate more cautious assumptions on revenue growth, profit margins, and future P/E multiples following a broad series of recent target cuts across the broker group. Analyst Commentary Recent research points to a clear shift toward more cautious assumptions on Ryan Specialty Holdings, with several firms trimming price targets and at least one downgrade reflecting concern around growth durability, margins, and valuation support.
Price Target Changed • Apr 10Price target decreased by 7.3% to US$49.65Down from US$53.53, the current price target is an average from 17 analysts. New target price is 44% above last closing price of US$34.57. Stock is down 53% over the past year. The company is forecast to post earnings per share of US$1.00 for next year compared to US$0.50 last year.
Major Estimate Revision • Apr 09Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.44b to US$3.39b. EPS estimate also fell from US$1.12 per share to US$1.01 per share. Net income forecast to grow 387% next year vs 3.7% growth forecast for Insurance industry in the US. Consensus price target down from US$53.53 to US$50.35. Share price rose 4.1% to US$34.89 over the past week.
お知らせ • Apr 07Ryan Specialty Holdings, Inc. to Report Q1, 2026 Results on Apr 30, 2026Ryan Specialty Holdings, Inc. announced that they will report Q1, 2026 results After-Market on Apr 30, 2026
ナラティブ更新 • Mar 31RYAN: AI Productivity And Capital Returns Will Support Future RepricingAnalysts have lowered price targets on Ryan Specialty Holdings by roughly $5 to $15 to reflect concerns about slower excess and surplus market growth and fears of AI-related disruption, even as some point to potential support from AI-driven productivity and margins that appear more resilient than recent trading suggests. Analyst Commentary Recent Street research on Ryan Specialty reflects a clear tilt toward more cautious views, with several firms cutting price targets and, in at least one case, lowering the stock rating.
ナラティブ更新 • Mar 17RYAN: Core Brokerage Role Will Benefit From AI Productivity TailwindThe updated analyst price target for Ryan Specialty Holdings edges up to $55.25 from $54.88, as analysts weigh softer revenue growth assumptions against slightly higher margin expectations and a modestly lower future P/E. They are also factoring in recent sector wide target cuts tied to AI disruption concerns and excess and surplus market deceleration.
ナラティブ更新 • Mar 03RYAN: Core Brokerage Role Will Withstand Softer P And C CycleAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings from about $66.53 to $54.88, reflecting lower Street price targets in the $43 to $65 range and updated expectations for slower revenue growth, softer profit margins, and a higher future P/E multiple. Analyst Commentary Recent Street research around Ryan Specialty Holdings has turned more cautious overall, with several firms cutting price targets and, in one case, lowering the rating.
New Risk • Feb 25New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Payout ratio: 96% Dividend yield: 1.4% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Dividend is not well covered by earnings (96% payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).
Recent Insider Transactions • Feb 25Director recently bought US$1.0m worth of stockOn the 23rd of February, Patrick Ryan bought around 26k shares on-market at roughly US$39.98 per share. This transaction amounted to 3.9% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold US$2.8m more in shares than they bought in the last 12 months.
Major Estimate Revision • Feb 20Consensus EPS estimates increase by 11%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from US$3.58b to US$3.46b. EPS estimate rose from US$1.02 to US$1.12. Net income forecast to grow 428% next year vs 9.7% growth forecast for Insurance industry in the US. Consensus price target down from US$64.31 to US$57.25. Share price fell 6.9% to US$41.33 over the past week.
ナラティブ更新 • Feb 17RYAN: Softening P&C Cycle And Capital Moves Will Shape Future RepricingAnalysts have trimmed the fair value estimate for Ryan Specialty Holdings to $43 from $52, reflecting updated views on slower revenue growth assumptions, slightly lower profit margins, and a reduced future P/E multiple across recent Street research. Analyst Commentary Recent Street research on Ryan Specialty Holdings has shifted in a more cautious direction, with several bearish analysts trimming price targets and highlighting potential pressure on growth, margins, and valuation multiples.
New Risk • Feb 16New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 3.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).
Declared Dividend • Feb 16Fourth quarter dividend increased to US$0.13Dividend of US$0.13 is 8.3% higher than last year. Ex-date: 24th February 2026 Payment date: 10th March 2026 Dividend yield will be 1.3%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is not adequately covered by earnings (96% earnings payout ratio). However, it is well covered by cash flows (24% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 2 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 7.1% to bring the payout ratio under control. EPS is expected to grow by 173% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
New Risk • Feb 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results.
Price Target Changed • Feb 13Price target decreased by 10.0% to US$58.25Down from US$64.69, the current price target is an average from 16 analysts. New target price is 50% above last closing price of US$38.71. Stock is down 44% over the past year. The company is forecast to post earnings per share of US$0.83 for next year compared to US$0.50 last year.
お知らせ • Feb 13+ 2 more updatesRyan Specialty Holdings, Inc., Annual General Meeting, Apr 28, 2026Ryan Specialty Holdings, Inc., Annual General Meeting, Apr 28, 2026.
お知らせ • Feb 05Ryan Specialty Appoints Stephen Stewart as CEO of Ryan Specialty Canada LimitedRyan Specialty announced the appointment of Stephen Stewart, President & CEO of Stewart Specialty Risk Underwriting, a Ryan Specialty managing general underwriter, to the additional role Chief Executive Officer of Ryan Specialty Canada Limited, the newly formed Canadian operating and holding entity for Ryan Specialty’s underwriting management businesses in Canada. Ryan Specialty Canada Limited is headquartered in Toronto. In Stephen Stewart’s additional role as CEO of Ryan Specialty Canada Limited, he will lead the continued growth of Ryan Specialty’s Canadian platform while maintaining the underwriting discipline and specialist focus that have defined Stewart Specialty Risk Underwriting and Ryan Specialty’s other Canadian units. The legal integration is already underway, and teams are actively engaging with new colleagues across underwriting, operations, and support functions to build a unified Canadian platform.
ナラティブ更新 • Feb 03RYAN: Double Digit Organic Expansion Is Expected To Sustain Earnings Through Softer P&C CycleAnalysts now estimate Ryan Specialty Holdings' fair value at about $80.34, up from $76.00. This change reflects updated assumptions for slower revenue growth, lower profit margins, and a higher future P/E multiple across recent P&C insurance sector research.
ナラティブ更新 • Jan 19RYAN: Softening P&C Cycle And Governance Shift Will Shape Future Share RepricingAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings to $52 from $58, reflecting a lower future P/E assumption, while updated models still factor in steady revenue growth and margins across a softening property and casualty cycle. Analyst Commentary Recent Street research on Ryan Specialty presents a mixed picture, with several firms trimming price targets even as some maintain positive ratings.
お知らせ • Jan 13Ryan Specialty Holdings, Inc. to Report Q4, 2025 Results on Feb 12, 2026Ryan Specialty Holdings, Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 12, 2026
ナラティブ更新 • Jan 05RYAN: Double Digit Organic Expansion Outlook Will Drive Future Share RepricingAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings to $58 from $60, reflecting updated views on revenue growth potential, profit margins, and a lower future P/E multiple after a mix of recent target cuts and raises across the Street. Analyst Commentary Recent Street research on Ryan Specialty Holdings shows a mix of optimism on the business model and caution on how much investors should be willing to pay for the stock.
ナラティブ更新 • Dec 18RYAN: Double Digit Organic Expansion Is Expected To Drive Strong Earnings AheadAnalysts have trimmed their price target for Ryan Specialty Holdings to $76 from $90, reflecting a modestly higher discount rate and more measured revenue growth expectations, even as they highlight resilient profit margins, double digit organic growth prospects into 2025 and 2026, and a still supportive earnings backdrop for property and casualty insurers. Analyst Commentary Bullish analysts acknowledge a reset in valuation assumptions but continue to frame Ryan Specialty as a long term compounder, citing durable organic growth, expanding distribution, and a supportive earnings environment for specialty focused intermediaries.
Recent Insider Transactions Derivative • Dec 16CEO & Director exercised options and sold US$6.9m worth of stockOn the 12th of December, Timothy Turner exercised options to acquire 130k shares at no cost and sold these for an average price of US$53.61 per share. This trade did not impact their existing holding. For the year to December 2020, Timothy's total compensation was 20% salary and 80% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Timothy's direct individual holding has increased from 8.10k shares to 12.55k. Company insiders have collectively sold US$46m more than they bought, via options and on-market transactions in the last 12 months.
お知らせ • Dec 09+ 1 more updateRyan Specialty Holdings, Inc. Announces Retirement of Bobby Le Blanc from Board of Directors, Effective February 11, 2026Ryan Specialty Holdings, Inc. announced that by mutual agreement following Onex Corporation’s sale of its remaining shares of Ryan Specialty, Bobby Le Blanc will retire from his service on the Ryan Specialty Board of Directors effective February 11, 2026. Mr. Le Blanc, Onex’ CEO, has served on Ryan Specialty’s Board since 2018, originally as Onex’ nominee with its investment in Ryan Specialty. Bobby Le Blanc contributed significantly to Ryan Specialty's growth and market leadership in specialty insurance solutions during his tenure on the board.
ナラティブ更新 • Dec 04RYAN: Double Digit Organic Expansion Will Outlast Softening Property And Casualty CycleAnalysts have trimmed their average price target on Ryan Specialty Holdings by about $2 to roughly $66.50. This reflects slightly lower assumptions for growth and margins amid softening property and casualty pricing, even as they continue to highlight the company's double digit organic revenue prospects and generally favorable long term earnings outlook.
ナラティブ更新 • Nov 20RYAN: Earnings Strength Will Overcome Sector Headwinds Into 2025Ryan Specialty Holdings' analyst price target saw a modest increase to $68.46, reflecting analyst expectations for slightly improved revenue growth and profit margins in light of resilient earnings and favorable industry conditions. Analyst Commentary Recent analyst coverage of Ryan Specialty Holdings reflects a nuanced perspective, with sentiment split between optimism about the firm's growth prospects and caution stemming from broader sector challenges.
New Risk • Nov 07New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.1% Last year net profit margin: 4.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.1% net profit margin).
Major Estimate Revision • Nov 06Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.69 to US$0.766. Revenue forecast steady at US$3.08b. Net income forecast to grow 319% next year vs 9.9% growth forecast for Insurance industry in the US. Consensus price target down from US$72.00 to US$68.31. Share price rose 12% to US$56.94 over the past week.
ナラティブ更新 • Nov 05RYAN: Ongoing Earnings Resilience And Sector Demand Will Drive Upside MomentumThe average analyst price target for Ryan Specialty Holdings has been revised downward by approximately $3.69 to $68.31. This reflects more cautious near-term assumptions on margin and sector growth trends, despite ongoing buy ratings and optimism around resilient earnings and organic growth.
分析記事 • Nov 03Ryan Specialty Holdings (NYSE:RYAN) Is Paying Out A Dividend Of $0.12The board of Ryan Specialty Holdings, Inc. ( NYSE:RYAN ) has announced that it will pay a dividend on the 25th of...
Declared Dividend • Nov 03Third quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 10th November 2025 Payment date: 25th November 2025 Dividend yield will be 0.9%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (16% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 148% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Oct 31Third quarter 2025 earnings: EPS in line with analyst expectations despite revenue beatThird quarter 2025 results: EPS: US$0.49 (up from US$0.15 in 3Q 2024). Revenue: US$754.6m (up 28% from 3Q 2024). Net income: US$62.6m (up 249% from 3Q 2024). Profit margin: 8.3% (up from 3.1% in 3Q 2024). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 31+ 1 more updateRyan Specialty Holdings, Inc. Declares A Regular Quarterly Dividend, Payable on November 25, 2025On October 30, 2025, Ryan Specialty Holdings, Inc.’s board of directors declared a regular quarterly dividend of $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on November 25, 2025, to stockholders of record as of the close of business on November 11, 2025.
ナラティブ更新 • Oct 22Analysts Weigh Resilient Margins and Growth Outlook for Ryan Specialty Holdings Amid Valuation ShiftsAnalysts have slightly lowered their average price target for Ryan Specialty Holdings, noting resilient profit margins and earnings support from lighter catastrophe losses even as the sector faces growth headwinds. Analyst Commentary Recent Street research on Ryan Specialty Holdings highlights a mix of optimism and caution, reflecting varying outlooks for the company as growth moderates in the broader insurance sector.
Major Estimate Revision • Oct 09Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.622 to US$0.693. Revenue forecast steady at US$3.07b. Net income forecast to grow 543% next year vs 13% growth forecast for Insurance industry in the US. Consensus price target broadly unchanged at US$71.85. Share price was steady at US$55.63 over the past week.
お知らせ • Oct 09Ryan Specialty Holdings, Inc. Announces Executive ChangesOn October 8, 2025, the Board of Directors of Ryan Specialty Holdings, Inc. (the Company" or Ryan Specialty") appointed Stephen P. Keogh as Co-President and Chief Operating Officer and Brendan M. Mulshine as Co-President and Chief Revenue Officer of the Company to succeed Jeremiah Bickham as President, effective October 9, 2025. Stephen P. Keogh, age 59, has served as the Company's Chief Operating Officer since May 2025. Previously, Mr. Keogh was the Senior Advisor to the Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that, commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management business of Aon. Mr. Keogh holds in excess of thirty-two years of experience at Aon, where he held positions in operations, finance and accounting, technology, human resources and executive management. Mr. Keogh earned a Bachelor's degree from the University of Illinois. Brendan M. Mulshine, age 59, has served as the Company's Executive Vice President and Chief Revenue Officer since 2020 and previously served as the Company's Executive Vice President and Managing Director from 2012 through 2020. From 1995 to 2012, Mr. Mulshine held various leadership positions at Aon Re, working with domestic and global insurance company clients on their reinsurance capital needs. Mr. Mulshine began his career practicing law in New York City. He earned a Bachelor of Arts from Yale College, a Juris Doctor from the University of Notre Dame School of Law, and a Master of Business Administration from Northwestern University's Kellogg School of Management. Changes to Messrs. On October 2, 2025, the Company and Mr. Jeremiah Bickham agreed that, effective October 8, 2025, Mr. Bickham would be transitioning from his role as President to serve as a non-employee strategic advisor to the Company through January 1, 2026.
ナラティブ更新 • Oct 08Emerging Risks And Data Analytics Will Expand Future OpportunitiesAnalysts have modestly reduced their price target for Ryan Specialty Holdings, citing commercial property growth headwinds and a slight decrease in projected revenue growth. The fair value estimate is now lowered by approximately $1.42 to $72.00 per share.
お知らせ • Oct 03Ryan Specialty Holdings, Inc. to Report Q3, 2025 Results on Oct 30, 2025Ryan Specialty Holdings, Inc. announced that they will report Q3, 2025 results After-Market on Oct 30, 2025
お知らせ • Sep 10Ryan Specialty Holdings, Inc. Appoints Michael G. Bungert to Its Board of Directors and Serves as A Member of Its Compensation and Governance Committee, Effective September 3, 2025Ryan Specialty Holdings, Inc. on September 3, 2025 elected Michael G. Bungert as a director and assigned him to its Compensation and Governance Committee, effective September 9, 2025. Mr. Bungert's initial term as a director will expire at the 2026 annual meeting of the Company's stockholders, at which time his continued Board service will be subject to renomination and stockholder approval. There are no transactions in which Mr. Bungert has or will have an interest that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K under the Exchange Act, at this time. The selection of Mr. Bungert was not pursuant to any arrangement or understanding between him and any other person. Mr. Bungert will participate in the Company's standard non-employee director compensation arrangements. Mr. Bungert will receive a grant of restricted stock units (RSUs) with a grant date fair value equal to $200,000 (prorated for the portion of the year for which he served as a director) that fully vest on the grant date and each RSU represents a right to receive one fully vested share of the Company's Class A common stock. The Company will make the annual equity grant of RSUs on the date of the Company's next annual meeting of stockholders and such grant will be compensation for the prior year of service, or portion thereof. Additionally, Mr. Bungert will be entitled to receive a cash payment in the amount of $120,000 per year, paid quarterly, in respect of his service as a member of the Board, with no additional cash compensation paid on account of his service on the Compensation and Governance Committee. Mr. Bungert has had a long and illustrious reinsurance career, most recently as Chairman of Aon Re Global from which he retired in 2024 after 11 years in that position. Prior to being Chairman, Mr. Bungert was CEO of Aon Re, a position he assumed in 1998. Mr. Bungert started his career in reinsurance in 1977 as an underwriter trainee at Continental Casualty Company. He then joined CNA Re in 1979 as a London-based North American underwriter. In 1984, Mr. Bungert joined reinsurance intermediary Thomas A. Greene Inc. Intermediaries in Chicago and subsequently joined Aon Re in 1989.
ナラティブ更新 • Sep 04Emerging Risks And Data Analytics Will Expand Future OpportunitiesAmid increased competition in personal auto, softened reinsurance pricing, and pressure on underwriting margins for carriers, analysts have adopted a more cautious outlook for the sector—though brokers like Ryan Specialty are expected to demonstrate relative earnings resilience—with the consensus price target remaining unchanged at $73.42. Analyst Commentary Increased competition in the personal auto insurance market and softened reinsurance pricing, resulting in a more cautious outlook and modest reductions of price targets.
Major Estimate Revision • Aug 07Consensus EPS estimates fall by 14%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$0.853 to US$0.733 per share. Revenue forecast steady at US$3.08b. Net income forecast to grow 571% next year vs 11% growth forecast for Insurance industry in the US. Consensus price target down from US$78.00 to US$75.60. Share price fell 2.7% to US$59.55 over the past week.
Declared Dividend • Aug 04Second quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 12th August 2025 Payment date: 26th August 2025 Dividend yield will be 0.8%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is not covered by earnings (233% earnings payout ratio). However, it is well covered by cash flows (25% cash payout ratio). The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years. The company's earnings per share (EPS) would need to grow by 159% to bring the payout ratio under control. EPS is expected to grow by 418% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
Reported Earnings • Aug 01Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2025 results: EPS: US$0.41 (up from US$0.38 in 2Q 2024). Revenue: US$855.2m (up 26% from 2Q 2024). Net income: US$124.7m (up 176% from 2Q 2024). Profit margin: 15% (up from 6.6% in 2Q 2024). Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) missed analyst estimates by 1.9%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 01+ 1 more updateRyan Specialty Holdings, Inc. Updates Earnings Guidance for the Full Year 2025Ryan Specialty Holdings, Inc. updated earnings guidance for the full year 2025. Organic Revenue Growth Rate guidance for full year 2025 is between 9.0% – 11.0%, compared to the company’s prior guidance of 11% – 13.0%.
お知らせ • Jul 18Ryan Specialty Holdings, Inc. Announces Board and Committee ChangesRyan Specialty Holdings, Inc. shared the sad news of the loss of Director, D. Cameron (“Cam”) Findlay, who unexpectedly passed away earlier this month. Mr. Findlay served on the Ryan Specialty Board, including its pre-IPO predecessor, since 2012, and was most recently the chairperson of the Compensation and Governance Committee, a member of the Executive Committee, and the Board’s Lead Director. From 2013 until his retirement in 2023, Mr. Findlay was the Senior Vice President, General Counsel, and Secretary of Archer Daniels Midland Company. From 2009 to 2013, he was Senior Vice President and General Counsel of Medtronic, Inc., and from 2003 to 2009 he served as Executive Vice President and General Counsel of Aon Corporation. In addition to his time as a lawyer and businessperson, Mr. Findlay had a distinguished career in government service, including at the White House as deputy assistant to President George H.W. Bush, at the U.S. Department of Labor as the deputy secretary of labor, at the U.S. Supreme Court as a law clerk for Justice Antonin Scalia, and at the U.S. Court of Appeals for the D.C. Circuit as a law clerk for Judge Stephen F. Williams. He earned his B.A. from Northwestern University, his Master of Arts (Oxon.) from Oxford University, and his Juris Doctor from Harvard Law School. On July 16, 2025, the Board appointed John W. Rogers, Jr. as Lead Director and Henry S. Bienen as Chairperson of the Compensation and Governance Committee.
お知らせ • Jul 15Ryan Specialty Holdings, Inc. to Report Q2, 2025 Results on Jul 31, 2025Ryan Specialty Holdings, Inc. announced that they will report Q2, 2025 results After-Market on Jul 31, 2025
お知らせ • Jul 02Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of JM Wilson Corporation.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire JM Wilson Corporation on June 5, 2025. JM Wilson is based in Michigan and its operations will become a part of RT Binding Authority, the binding authority specialty of Ryan Specialty.JM Wilson generated approximately $19 million of operating revenue for the 12 months ended January 31, 2025. The transaction is expected to close in the third quarter of 2025. Philo Smith & Co. acted as financial advisor for JM Wilson Corporation. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of JM Wilson Corporation on July 1, 2025.
Recent Insider Transactions • May 20President recently sold US$3.5m worth of stockOn the 16th of May, Jeremiah Bickham sold around 50k shares on-market at roughly US$70.09 per share. This transaction amounted to 96% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Jeremiah's only on-market trade for the last 12 months.
Major Estimate Revision • May 09Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$1.12 to US$0.858 per share. Revenue forecast steady at US$3.08b. Net income forecast to grow 524% next year vs 12% growth forecast for Insurance industry in the US. Consensus price target of US$75.90 unchanged from last update. Share price rose 8.2% to US$70.13 over the past week.
Declared Dividend • May 05First quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 13th May 2025 Payment date: 27th May 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 108%. Cash payout ratio: 29%.
New Risk • May 02New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.9% Last year net profit margin: 3.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin).
Reported Earnings • May 02First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2025 results: US$0.22 loss per share (down from US$0.14 profit in 1Q 2024). Revenue: US$690.2m (up 28% from 1Q 2024). Net loss: US$4.39m (down 127% from profit in 1Q 2024). Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
お知らせ • May 02+ 1 more updateRyan Specialty Holdings, Inc. Declares Regular Quarterly Dividend, Payable on May 27, 2025On May 1, 2025, the board of directors of Ryan Specialty Holdings, Inc. declared a regular quarterly dividend of $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on May 27, 2025 to stockholders of record as of the close of business on May 13, 2025. A portion of the dividend, $0.05 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company's Class A common stock and the holders of the LLC Common Units.
お知らせ • Apr 07Ryan Specialty Holdings, Inc., Annual General Meeting, May 30, 2025Ryan Specialty Holdings, Inc., Annual General Meeting, May 30, 2025.
お知らせ • Apr 04Ryan Specialty Holdings, Inc. to Report Q1, 2025 Results on May 01, 2025Ryan Specialty Holdings, Inc. announced that they will report Q1, 2025 results After-Market on May 01, 2025
お知らせ • Mar 28Ryan Specialty Holdings, Inc. Appoints Stephen P. Keogh as Chief Operating Officer, Effective May 1, 2025On March 27, 2025, Ryan Specialty Holdings, Inc. announced the appointment of Mr. Stephen P. Keogh to the position of Chief Operating Officer of the Company, effective May 1, 2025. Stephen P. Keogh, age 58, was most recently Senior Advisor to the Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that, commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management business of Aon. Mr. Keogh brings in excess of thirty- two years of experience at Aon, where he held positions in operations, finance and accounting, technology, human resources and executive management. Mr. Keogh is a member of the Board of Trustees of the Illinois Institute of Chicago and earned a Bachelor’s degree from the University of Illinois.
Recent Insider Transactions Derivative • Mar 18Executive VP & Chief Revenue Officer exercised options and sold US$2.1m worth of stockOn the 14th of March, Brendan Mulshine exercised options to acquire 30k shares at no cost and sold these for an average price of US$69.30 per share. This trade did not impact their existing holding. Since June 2024, Brendan's direct individual holding has decreased from 76.50k shares to 75.82k. Company insiders have collectively sold US$179m more than they bought, via options and on-market transactions in the last 12 months.
Major Estimate Revision • Feb 28Consensus EPS estimates fall by 12%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from US$3.02b to US$3.05b. EPS estimate fell from US$1.44 to US$1.27 per share. Net income forecast to grow 212% next year vs 9.4% growth forecast for Insurance industry in the US. Consensus price target broadly unchanged at US$75.60. Share price rose 2.1% to US$70.03 over the past week.
Declared Dividend • Feb 25Fourth quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 4th March 2025 Payment date: 18th March 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 56%. Cash payout ratio: 27%.
New Risk • Feb 24New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 33% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Significant insider selling over the past 3 months (US$34m sold).
お知らせ • Feb 21+ 1 more updateRyan Specialty Holdings, Inc. Declares Regular Quarterly Dividend on Outstanding Class A Common Stock, Payable on March 18, 2025On February 20, 2025, Ryan Specialty Holdings, Inc. declared and increased the Company's regular quarterly dividend by 9.1% to $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on March 18, 2025 to stockholders of record as of the close of business on March 4, 2025. A portion of the dividend, $0.05 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company's Class A common stock and the holders of the LLC Common Units.
お知らせ • Feb 04Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others for approximately $530 million on January 7, 2025. The upfront cash consideration is exclusive of VSIC and any earnout consideration. Velocity generated approximately $81 million of operating revenue for the 12 months ended December 31, 2024. The acquisition of Velocity is expected to close in early 2025. Andrew Jamieson of Debevoise & Plimpton LLP acted as legal advisor to Oaktree and Velocity Risk. Howden Tiger Capital Markets & Advisory, LLC acted as financial advisor to Oaktree and Velocity Risk. Insurance Advisory Partners LLC acted as financial advisor to Oaktree and Velocity Risk. Sidley Austin LLP acted as legal advisor to Ryan Specialty. J.P. Morgan Securities LLC acted as financial advisor to Ryan Specialty. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others on February 3, 2025.
Recent Insider Transactions • Jan 16Director recently sold US$6.5m worth of stockOn the 15th of January, Nicholas Cortezi sold around 99k shares on-market at roughly US$65.50 per share. This transaction amounted to 28% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth US$7.0m. Insiders have been net sellers, collectively disposing of US$25m more than they bought in the last 12 months.
お知らせ • Jan 10Ryan Specialty Holdings, Inc. to Report Q4, 2024 Results on Feb 20, 2025Ryan Specialty Holdings, Inc. announced that they will report Q4, 2024 results After-Market on Feb 20, 2025
